Novo Nordisk shares plunge 10% after Alzheimer’s drug trial fails to hit key target

Shares of Novo Nordisk on Monday fell 10% after the Danish drug pharmaceutical company said a highly-anticipated trial for Alzheimer’s disease failed to meet it…

Source : cnbc.com